Ovarian cancer metastasis study identifies important protein with potential as diagnostic tool and treatment option
Advanced ovarian cancer most commonly metastasizes to the omentum, a layer of fatty tissue that wraps around and protects internal organs in the abdomen, but the reasons for this have not been well-understood. In a new study, MD Anderson researchers discovered that a protein called omentin, or ITLN1, works to prevent metastasis of the cancer cells, but it is lost as the cancer develops.
Their preclinical findings, published in...
BIA-ALCL study shows multi-team treatment key to achieving best outcomes
A team of researchers from across five disciplines at MD Anderson recently published the largest prospective study on breast implant associated...
Study shows Enhanced Recovery After Surgery lowers pain and opioid use for lung cancer patients
MD Anderson surgeons have found a way to reduce pain and opioid use for lung cancer patients undergoing a lung...
Twelve MD Anderson researchers honored with 2020 AACR Team Science Awards
The American Association for Cancer Research (AACR) is recognizing the founding members of The Cancer Genome Atlas (TCGA) and the current project team with 2020 AACR Team Science Awards. These teams will be honored during the AACR Virtual Annual Meeting II on June 24.
The Cancer Genome Atlas was launched in 2006 as a joint endeavor between the National Cancer Institute (NCI) and the National Human...
Brain metastases recruit suppressive immune cells via novel pathway to facilitate their growth
MD Anderson researchers have discovered that metastatic cancer cells in the brain upregulate expression of the EZH2 gene to activate a previously...
Cancer-associated fibroblasts fuel breast cancer growth
Researchers at MD Anderson have discovered that cancer-associated fibroblasts (CAF) help fuel the growth of breast tumors. Their findings...
ASCO: Palliative and supportive care interventions increase comfort in advanced cancer patients
Two studies presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting highlighted MD Anderson’s commitment to holistic...
ASCO: Updated targeted therapy clinical trials results continue to show improved outcomes for advanced colorectal and bladder cancers
Updated results from two MD Anderson clinical trials presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting indicate...
ASCO: Developing effective combination therapies for leukemia
Findings from three studies led by researchers at MD Anderson suggest that new combination therapies are safe and effective against various...
ASCO: Advances in T cell therapies for lymphomas
Two studies led by MD Anderson researchers explore advancements in CAR T cell therapy for non-Hodgkin lymphomas. CAR T cell therapy is commonly...